A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis

  • Sparrow, Miles (Primary Chief Investigator (PCI))
  • McKenzie, Jo (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date26/05/21 → 31/12/23

Keywords

  • Ulcerative colitis
  • Clinical trial